Cited by 49Neuroendocrine Tumor Research AdvancesClinical Nutrition and GastroenterologyPancreatic function and diabetes

Increased amino acid clearance and urea synthesis in a patient with glucagonoma.

Open access
Almdal, T P, Heindorff, H, Bardram, L, Vilstrup, H·1990·Gut

Abstract

Fasting concentrations, clearance of exogenous infused amino acids, and lean body mass were studied in a patient with glucagonoma syndrome (fasting glucagon = 380 pmol/l, normal range 15-45 pmol). The fasting concentrations of all amino acids were reduced. The clearances of alanine, arginine, glycine, isoleucine, leucine, lysine, methionine, proline, serine, threonine, and tyrosine were increased. The urea synthesis rate during amino acid infusion was 27 mumols/kg per minute (normal range 20-24 mumols/kg per minute). The lean body mass of the patients was reduced to 59% of the expected value. It is suggested that the weight loss of patients with glucagonoma syndrome is partly due to increased hepatic conversion of amino acid nitrogen to urea nitrogen, resulting in decreased blood amino acid concentration, and secondary to this, organ protein catabolism, as shown by the decreased lean body mass.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.31.8.946

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glucagonoma is characterised by very high levels of circulating GCG, low levels of amino-acids, and sarcopenia.

    “An extreme example of the effects of GCG on lean mass is in individuals with glucagonoma, which is characterised by very high levels of circulating GCG, low levels of amino-acids, and sarcopenia [61, 62].”

    From Triple Agonism Based Therapies for Obesity (2025) · cites this paper as [61]

    The Case report records markedly elevated plasma glucagon, and the Results report reduced fasting concentrations of all amino acids and lean body mass at 59% of the expected value in one patient. The paper supports loss of lean mass but does not specifically establish sarcopenia or show that it characterises people with glucagonoma generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Lindberg W, Natvig H, Rygh A, Svendsen K. Weight and height in adult men and women. TidskrNorLaegeforen 1956; 361-8.
  2. Vilstrup H, Hansen BA, Almdal T, Petersen KF, Sigsgaard, Poulsen HE. The capacity of urea synthesis in rats: regulation and physiological importance. In: Soeters PB. Wilson JHP, Meijer AJ, Holm E, eds. Advances in ammonia metabolism and hepatic encephalopathy. Amsterdam: Excerpta Medica, 1988: 79-85.

Cited by

Sorted by citations

Authors
Almdal, T. P., Heindorff, H., Bardram, L., & Vilstrup, H.
Affiliations
Rigshospitalet (DK)
Venue
Gut
Publisher
BMJ
Published
1990-08
Volume
31
Issue
8
Pages
946-948
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2024131582
Cited by
49
References
15
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 1 · 2012: 3
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
glucagonoma, glucagonoma syndrome, amino acid clearance, urea synthesis, weight loss, lean body mass, protein degradation, amino acid infusion
MeSH terms
Amino Acids, Female, Glucagonoma, Humans, Adenoma, Islet Cell, Middle Aged, Pancreatic Neoplasms, Urea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review